governmentEvidence level AIndependent
Evidence pageFDA Executive Summary: General Issues Panel Meeting on Dermal Fillers
U.S. Food and Drug Administration
accessed Nov 10, 2026Updated Nov 10, 2026
Original source
https://www.fda.gov/media/188185/download
fda.gov
Verification
| Verification | Independent of the subject |
| Evidence level | A · Government / regulator |
| Independent | Independent of the subject |
| Source | government |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (3)
FactDermal Filler: US regulatory status = Class III medical device that needs premarket approval (PMA); FDA product codes LMH (face) and PKY (back of hand)FactDermal Filler: Materials in FDA-approved fillers = Mostly bacterial-source cross-linked hyaluronic acid; also calcium hydroxylapatite and poly-L-lactic acidFactDermal Filler: Newer US-approved indications = Infraorbital hollowing, jawline and temple, in addition to lips, cheeks, perioral lines and nasolabial folds (approvals are product-specific)